Get the Stockscreener App
1.47
4.26%
0.06
Biorestorative Therapies Inc stock is traded at $1.47, with a volume of 29,257.
It is up +4.26% in the last 24 hours and down -9.26% over the past month.
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
See More
Previous Close:
$1.41
Open:
$1.41
24h Volume:
29,257
Relative Volume:
0.24
Market Cap:
$11.03M
Revenue:
$149.50K
Net Income/Loss:
$-6.96M
P/E Ratio:
-1.0809
EPS:
-1.36
Net Cash Flow:
$-6.37M
1W Performance:
-1.34%
1M Performance:
-9.26%
6M Performance:
-38.49%
1Y Performance:
+2.80%
1-Day Range:
$1.405
$1.47
1-Week Range:
$1.38
$1.50
52-Week Range:
$1.21
$2.55
Biorestorative Therapies Inc Stock (BRTX) Company Profile
Name
Biorestorative Therapies Inc
Sector
Industry
Phone
(631) 760-8100
Address
40 MARCUS DRIVE, MELVILLE
Compare BRTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRTX
Biorestorative Therapies Inc
|
1.47 | 10.58M | 149.50K | -6.96M | -6.37M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Biorestorative Therapies Inc Stock (BRTX) Latest News
Biorestorative Therapies: A Regenerative Medicine Play with Dual Catalysts - AInvest
Key resistance and support levels for BioRestorative Therapies Inc. [Weekly Stock Report]AI Driven Stock Movement Reports - Newser
Advanced analytics toolkit walkthrough for BioRestorative Therapies Inc. [Long Setup]Low Drawdown Momentum Ideas - Newser
Tools to assess BioRestorative Therapies Inc.’s risk profile [Weekly Trend Summary]AI Enhanced Market Trend Forecasts - Newser
BioRestorative Therapies Reports Strong Q2 2025 Growth - TipRanks
Will BioRestorative Therapies Inc. see short term momentumStock Market Watch with Smart Filters - Newser
BioRestorative Therapies earnings beat by $0.08, revenue fell short of estimates - Investing.com Canada
Is now a turning point for BioRestorative Therapies Inc.Machine Learning Stock Movement Detector - Newser
BioRestorative Therapies Q2 2025 Earnings Call Transcript - AInvest
Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Beats Revenue Estimates - Nasdaq
Transcript : BioRestorative Therapies, Inc., Q2 2025 Earnings Call, Aug 12, 2025 - MarketScreener
Earnings call transcript: BioRestorative Therapies reports Q2 2025 earnings - Investing.com
Earnings call transcript: BioRestorative Therapies reports Q2 2025 earnings By Investing.com - Investing.com UK
BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update - Ortho Spine News
BioRestorative Therapies Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Applying big data sentiment scoring on BioRestorative Therapies Inc.Trade Safety Report with Pattern Insights - Newser
BioRestorative's Spine Treatment Exceeds FDA Targets as Q2 Revenue Triples - Stock Titan
Candlestick signals on BioRestorative Therapies Inc. stock todayWeekly Movement Forecast With Chart Signals - Newser
Why BioRestorative Therapies Inc. stock attracts strong analyst attentionStock Entry Points Based on Technicals - Newser
Published on: 2025-08-12 01:40:04 - Newser
Does BioRestorative Therapies Inc. have a sustainable dividendFree Price Action Training - newsyoung.net
Visual trend scoring systems applied to BioRestorative Therapies Inc.Breakout Stock Opportunities with Low Drawdown - Newser
How BioRestorative Therapies Inc. stock performs during market volatilityFree Consistent Profit Pattern Recognition Tools - Newser
What indicators show strength in BioRestorative Therapies Inc.Price Spike Prediction for Active Traders - Newser
Combining machine learning predictions for BioRestorative Therapies Inc.Free Watchlist for Smart Swing Trading - Newser
Technical signs of recovery in BioRestorative Therapies Inc.High Reward Investment Strategy for Beginners - Newser
How high can BioRestorative Therapies Inc. stock goFree Fast Gaining Stock Screener Report - Newser
What’s next for BioRestorative Therapies Inc. stock priceFast Entry Strategy with Price Prediction - Newser
Can technical indicators confirm BioRestorative Therapies Inc.’s reversalFree Community Entry Consensus Trade Ideas - Newser
Tools to assess BioRestorative Therapies Inc.’s risk profileFree Secure Capital Picks With Upside Potential - Newser
Published on: 2025-08-10 20:16:08 - Newser
Forecasting BioRestorative Therapies Inc. price range with options dataSmart Trend Analysis With Buy Point Cues - Newser
Biorestorative Therapies (BRTX) to Release Earnings on Tuesday - Defense World
Candlestick Signal Suggests Reversal in BioRestorative Therapies Inc.Buy Signal Based on Chart Analysis Confirmed - metal.it
Key resistance and support levels for BioRestorative Therapies Inc.Low-Risk Reversal Pattern Analysis Tracker - Newser
BRTX SEC FilingsBiorestorative Therapies Inc 10-K, 10-Q, 8-K Forms - Stock Titan
BioRestorative Therapies Inc expected to post a loss of 38 cents a shareEarnings Preview - TradingView
Real time scanner hits for BioRestorative Therapies Inc. explainedFree Weekly Stock Watch With Growth Focus - Newser
Will BioRestorative Therapies Inc. rebound enough to break evenGrowth Projection Summary for Long-Term Investors - Newser
Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
BioRestorative Therapies Announces Q2 2025 Financial Results and Hosts Conference Call on August 12, 2025 - AInvest
Pattern recognition hints at BioRestorative Therapies Inc. upsideConsistent Gain Plan with AI Support - Newser
BioRestorative Therapies, Inc. to Announce Second Quarter 2025 Financial Results and Host Conference Call - Quiver Quantitative
Clinical Stage Stem Cell Therapy Pioneer BioRestorative Sets Q2 2025 Earnings Date - Stock Titan
Biorestorative Therapies Inc Stock (BRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.91%
3.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):